A major pharmaceutical company that has invested heavily in North Carolina is planning multiple new factories in the U.S.
In addition, due for completion in 2027 is the company’s $1.7 billion plant in Concord, North Carolina. All told, Eli Lilly has tallied up about $23 billion in U.S. manufacturing commitments in ...
Eli Lilly has announced plans to expand its domestic medicine production in the US by establishing four new pharmaceutical manufacturing sites. The move increases the company's total US capital ...
The pharmaceutical firm is growing its presence across three states, creating 3,000 jobs.
The new manufacturing sites are expected to create create 3,000 pharmaceutical jobs and nearly 10,000 construction positions during the buildout.
At the four new sites, Lilly expects to create more than 3,000 jobs for engineers, scientists, operations personnel, and lab ...
Elsewhere in the state, Eli Lilly has invested heavily in a manufacturing campus in Concord. The company last ... buildout," said CEO David Ricks. NC firm backed by Eli Lilly, Merck raises $ ...